This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In a recent study , researchers aimed to discover how much of the antidepressant research literature is valid and how much is “hijacked for marketing purposes.” They looked at the largest, most influential clinical trials of antidepressants and found that almost half were so biased that they could be considered “seeding trials”—or studies that provide marketing materials for the pharmaceutical industry, not valid scientific data.
In the latest installment of the Anxiety Guy podcast, I’m excited to unveil an incredibly potent method for journaling your way through anxiety. Tune in, absorb the wisdom, and don’t forget to pass it along to those who could benefit on their journey to overcoming anxiety. Along with today’s journaling for anxiety technique I believe it’s also important to share with you some lessons I personally have come across in relation to journaling.
Editor’s Note: This article is being simultaneously published on our affiliate site, Mad in the UK. T his is intended as the first part of a look at pathways and outcomes in ‘psychosis’ and ‘schizophrenia’. Here, I discuss some of what’s not right in the picture for the current paradigm; an approach which, in essence, dates from the 1950s. By way of introduction, let’s consider a finding from decades ago.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
While harmful physical effects of the use of antipsychotics are often discussed, one crucial adverse effect is often left out: their impact on identity. A new article by Maev Connely from the University College London in the Division of Psychiatry and colleagues argues for increased understanding and discussions of antipsychotics (APs) impact on identity and sense of self.
I arrived at my 18 th birthday 20 pounds overweight, insecure, and foggy, thanks to Depakote and Zyprexa. It was the perfect way to start my senior year of high school. My lovely psychiatrist, Dr. Volls, advised me on the concept of “mood management.” I depended on her expertise to keep me out of crisis, while the medication kept me grounded, sleeping, and helped me forget.
I kept telling her that Carsten Dahl is not Carson Dyle for the obvious reason the former doodles Danish bebop on the piano with a sort of Gouldian passion for counterpoint, whereas the latter is a character played by Walter Matthau, whose fervor is fuelled by revenge, avarice and triangle-cut sandwiches, in that wild caper of a movie called Charade.
I kept telling her that Carsten Dahl is not Carson Dyle for the obvious reason the former doodles Danish bebop on the piano with a sort of Gouldian passion for counterpoint, whereas the latter is a character played by Walter Matthau, whose fervor is fuelled by revenge, avarice and triangle-cut sandwiches, in that wild caper of a movie called Charade.
T hanks to excellent work of Mark Horowitz and David Taylor we now have the Maudsley Deprescribing Guidelines for Antidepressants, Benzodiazepines, Gabapentinoids, and Z-drugs. I consider this very good news for all who want to taper withdrawal-causing prescription drugs safely, and for all who want to help them as best as they can. The new guidance offers strong and comprehensive support and will aid development of new guidelines and will help to improve existing ones.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
145 
Let's personalize your content